Skip to content
  • Home
  • Issue
  • Drug Info
  • About

Jason P.

Plain-language health writer for EasyReadRx. Not a medical professional.

Adult RSV and Pneumococcal Vaccines: Who Should Get Them?

18/06/2026 by Jason P.

A plain-English guide to which adults should review RSV and pneumococcal vaccine eligibility, how the timing differs, what side effects to expect, and what to ask before the shot.

Categories Issue

Black Box Warning: 5 Safety Checkpoints to Review Before Taking a High-Risk Medicine

17/06/2026 by Jason P.

A plain-English guide to FDA boxed warnings, label changes, side effects, insurance coverage, and safer medication conversations.

Categories Issue

Atorvastatin: Uses, Side Effects, Warnings, and Safety Checks

15/06/202615/06/2026 by Jason P.

Learn what atorvastatin is used for, common side effects, serious warnings, interactions, pregnancy and breastfeeding notes, and when to seek help.

Categories Drug Info

Why U.S. Prescription Drug Prices Are Actually Falling: DTP Programs, Insulin Caps, Medicare Negotiation, and State Laws

15/06/202613/06/2026 by Jason P.

A plain-English guide to why some prescription drug prices and out-of-pocket costs are changing in the U.S., including direct-to-patient programs, Medicare negotiation, insulin caps, PBM rules, and state affordability laws.

Categories Issue

FDA’s Proposed 503B Exclusion for GLP-1 Compounds: What It Means for Patients

15/06/202612/06/2026 by Jason P.

FDA has proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. Here is what that could mean for compounded GLP-1 medicines, safety checks, and patient questions.

Categories Issue

Recent Posts

  • Adult RSV and Pneumococcal Vaccines: Who Should Get Them?
  • Black Box Warning: 5 Safety Checkpoints to Review Before Taking a High-Risk Medicine
  • Atorvastatin: Uses, Side Effects, Warnings, and Safety Checks
  • Why U.S. Prescription Drug Prices Are Actually Falling: DTP Programs, Insulin Caps, Medicare Negotiation, and State Laws
  • FDA’s Proposed 503B Exclusion for GLP-1 Compounds: What It Means for Patients

Recent Comments

No comments to show.
About Contact Privacy Policy Terms Editorial Policy Affiliate Disclosure